Ubiquitination of p27Kip1 requires physical interaction with cyclin E and probable phosphate recognition by SKP2
- PMID: 15980415
- DOI: 10.1074/jbc.M411103200
Ubiquitination of p27Kip1 requires physical interaction with cyclin E and probable phosphate recognition by SKP2
Abstract
p27Kip1 is an essential cell cycle inhibitor of Cyclin-dependent kinases. Ubiquitin-mediated proteolysis of p27Kip1 is an important mechanism for activation of Cyclin E-Cdk2 and facilitates G1/S transition. Ubiquitination of p27 is primarily catalyzed by a multisubunit E3 ubiquitin ligase, SCF(Skp2), and requires an adapter protein Cks1. In addition, phosphorylation of p27 at Thr187 by Cyclin E and Cdk2 is also essential for triggering substrate ubiquitination. Here we investigate the molecular mechanism of p27 ubiquitination. We show that Cyclin E-Cdk2 is essential for targeting the p27 substrate to SCF(Skp2). Direct physical contact between Cyclin E but not Cdk2 and p27 is required for p27 recruitment to SCF(Skp2). In a search for positively charged amino acid residues that may be involved in recognition of the Thr187 phosphate group, we found that Arg306 of Skp2 is required for association and ubiquitination of phosphorylated p27 but dispensable for ubiquitination of unphosphorylated p21. Thus, our data unravel the molecular organization of the ubiquitination complex that catalyzes p27 ubiquitination and provide unique insights into the specificity of substrate recognition by SCF(Skp2).
Similar articles
-
Substrate recognition and ubiquitination of SCFSkp2/Cks1 ubiquitin-protein isopeptide ligase.J Biol Chem. 2007 May 25;282(21):15462-70. doi: 10.1074/jbc.M610758200. Epub 2007 Apr 4. J Biol Chem. 2007. PMID: 17409098
-
Discriminative SKP2 Interactions with CDK-Cyclin Complexes Support a Cyclin A-Specific Role in p27KIP1 Degradation.J Mol Biol. 2021 Mar 5;433(5):166795. doi: 10.1016/j.jmb.2020.166795. Epub 2021 Jan 7. J Mol Biol. 2021. PMID: 33422522 Free PMC article.
-
A negatively charged amino acid in Skp2 is required for Skp2-Cks1 interaction and ubiquitination of p27Kip1.J Biol Chem. 2003 Aug 22;278(34):32390-6. doi: 10.1074/jbc.M305241200. Epub 2003 Jun 16. J Biol Chem. 2003. PMID: 12813041
-
Targeting the untargetable: RB1-deficient tumours are vulnerable to Skp2 ubiquitin ligase inhibition.Br J Cancer. 2022 Oct;127(6):969-975. doi: 10.1038/s41416-022-01898-0. Epub 2022 Jun 25. Br J Cancer. 2022. PMID: 35752713 Free PMC article. Review.
-
The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer.J Gastrointestin Liver Dis. 2015 Jun;24(2):225-34. doi: 10.15403/jgld.2014.1121.242.skp2. J Gastrointestin Liver Dis. 2015. PMID: 26114183 Review.
Cited by
-
Tanshinone IIA inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation via Akt/Skp2/p27-associated pathway.PLoS One. 2013;8(2):e56774. doi: 10.1371/journal.pone.0056774. Epub 2013 Feb 21. PLoS One. 2013. PMID: 23437233 Free PMC article.
-
Dual effects of Ral-activated pathways on p27 localization and TGF-β signaling.Mol Biol Cell. 2013 Jun;24(11):1812-24. doi: 10.1091/mbc.E13-01-0007. Epub 2013 Apr 10. Mol Biol Cell. 2013. PMID: 23576547 Free PMC article.
-
Binimetinib, a novel MEK1/2 inhibitor, exerts anti-leukemic effects under inactive status of PI3Kinase/Akt pathway.Int J Hematol. 2019 Aug;110(2):213-227. doi: 10.1007/s12185-019-02667-1. Epub 2019 May 25. Int J Hematol. 2019. PMID: 31129802
-
A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression.Genes Dev. 2006 Jan 1;20(1):47-64. doi: 10.1101/gad.1384406. Genes Dev. 2006. PMID: 16391232 Free PMC article.
-
Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative disease.Blood. 2008 Sep 1;112(5):1960-70. doi: 10.1182/blood-2007-09-113860. Epub 2008 Jun 17. Blood. 2008. PMID: 18559973 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous